SAT660 Predictors Of Achieving Body Weight Reduction ≥20% With Tirzepatide In People With Overweight Or Obesity In SURMOUNT-1

Disclosure: R. Srinath: Grant Recipient; Self; Dexcom. S. Pedersen: Other; Self; AstraZeneca, Bausch, Eli Lilly & Company, Novo Nordisk, Jansen Pharmaceuticals, Boehringer Ingelheim, Sanofi, Merck, Abbott Laboratories, HLS, Bayer, Inc., Pfizer, Inc., Dexcom. L. Neff: Employee; Self; Eli Lilly &a...

Descripción completa

Detalles Bibliográficos
Autores principales: Srinath, Reshmi, Pedersen, Sue, Neff, Lisa, Cao, Dachuang, Kao, Christi Y, Stefanski, Adam, Ahmad, Nadia, Eun Lee, Clare Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554080/
http://dx.doi.org/10.1210/jendso/bvad114.108

Ejemplares similares

Ejemplares similares